188
Views
4
CrossRef citations to date
0
Altmetric
Review

Novel devices to monitor heart failure and minimize hospitalizations

, , , &
Pages 905-913 | Received 21 Mar 2016, Accepted 04 May 2016, Published online: 28 May 2016

References

  • Braunwald E. Heart failure. JACC Heart Fail. 2013;1(1):1–20. Epub 2013 Feb 4. Review. PMID: 24621794. doi:10.1016/j.jchf.2012.10.002.
  • Forleo GB, Panattoni G, Schirripa V, et al. Device monitoring of heart failure in cardiac resynchronization therapy device recipients: a single-center experience with a novel multivector impedance monitoring system. J Cardiovasc Med (Hagerstown). 2013;14(10):726–732. doi:10.2459/JCM.0b013e3283650587.
  • Mosterd A, Hoes AW. Clinical epidemiology of heart failure. Heart. 2007;93:1137–1146.
  • McMurray JJV, Adamopoulos S, Anker SD, et al.; ESC Committee for Practice Guidelines. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2012;14(8):803–869. No abstract available. Erratum in: Eur J Heart Fail. 2013 Mar; 15(3):361–362. doi:10.1093/eurjhf/hfs105.
  • Seferovic PM, Stoerk S, Filippatos G, et al.; Committee of National Heart Failure Societies or Working Groups of the Heart Failure Association of the European Society of Cardiology. Organization of heart failure management in European Society of Cardiology member countries: survey of the Heart Failure Association of the European Society of Cardiology in collaboration with the Heart Failure National Societies/Working Groups. Eur J Heart Fail. 2013;15(9):947–959. Epub 2013 Jun 19. doi:10.1093/eurjhf/hft092.
  • Mozaffarian D, Benjamin EJ, Go AS, et al.; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2016 update: a report from the American Heart Association. Circulation. 2016;133(4):e38–e360.
  • von Lueder TG, Krum H. Current modalities for invasive and non-invasive monitoring of volume status in heart failure. Heart. 2012;98(13):967–973. Epub 2012 May 9. Review. doi:10.1136/heartjnl-2011-301330.
  • Heidenreich PA, Albert NM, Allen LA, et al.; on behalf of the American Heart Association Advocacy Coordinating Committee; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular Radiology and Intervention; Council on Clinical Cardiology; Council on Epidemiology and Prevention; Stroke Council. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail. 2013;6:606–619. doi:10.1161/.HHF.0b013e318291329a.
  • Desai AS. Implantable hemodynamic monitoring in ambulatory heart failure: who, when, why, how? Curr Cardiol Rep. 2015;17(12):113. PMID: 26482756. doi:10.1007/s11886-015-0669-6.
  • Go AS, Mozaffarian D, Roger VL, et al.; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Executive summary: heart disease and stroke statistics–2013 update: a report from the American Heart Association. Circulation. 2013;127(1):143–152. Review. doi:10.1161/CIR.0b013e318282ab8f.
  • Guha K, McDonagh T. Heart failure epidemiology: European perspective. Curr Cardiol Rev. 2013;9(2):123–127. Review.
  • Braunschweig F, Cowie MR, Auricchio A. What are the costs of heart failure? Europace. 2011;13 Suppl 2:ii13–ii17. doi:10.1093/europace/eur081.
  • Miró Ò, Peacock FW, McMurray JJ, et al.; Acute Heart Failure Study Group of the ESC Acute Cardiovascular Care Association. European Society of Cardiology - Acute Cardiovascular Care Association position paper on safe discharge of acute heart failure patients from the emergency department. Eur Heart J Acute Cardiovasc Care. 2016. pii:2048872616633853.
  • Sicras Mainar A, Navarro Artieda R, Ibáñez Nolla J. Economic impact of heart failure according to the effects of kidney failure. Rev Esp Cardiol (Engl Ed). 2015;68(1):39–46. Epub 2014 Jul 23. doi:10.1016/j.rec.2014.02.021.
  • Setoguchi S, Stevenson LW. Hospitalizations in patients with heart failure: who and why. J Am Coll Cardiol. 2009;54(18):1703–1705. doi:10.1016/j.jacc.2009.08.015.
  • McDonagh TA, Blue L, Clark AL, et al.; European Society of Cardiology Heart Failure Association Committee on Patient Care. European Society of Cardiology Heart Failure Association Standards for delivering heart failure care. Eur J Heart Fail. 2011;13(3):235–241. doi:10.1093/eurjhf/hfq221.
  • Santini L, Papavasileiou LP, Santini M. [Remote monitoring of atrial fibrillation and heart failure]. G Ital Cardiol (Rome). 2013;14(4):253–261.
  • Papavasileiou LP, Forleo GB, Panattoni G, et al. Work burden with remote monitoring of implantable cardioverter defibrillator: is it time for reimbursement policies? J Cardiovasc Med (Hagerstown). 2013;14(2):114–119. doi:10.2459/JCM.0b013e328354e3e1.
  • Heart failure society of America. Module 4: Self Care-Following Your Treatment Plan and Dealing with your Symptoms [Internet]. [cited 2016 Mar 20]. Available from: hhtp//www.hfsa.org/hfsa-wp/wp/module-4.
  • Anand IS, Greenberg BH, Fogoros RN, et al.; Music Investigators. Design of the Multi-Sensor Monitoring in Congestive Heart Failure (MUSIC) study: prospective trial to assess the utility of continuous wireless physiologic monitoring in heart failure. J Card Fail. 2011;17(1):11–16. doi:10.1016/j.cardfail.2010.08.001.
  • Anand IS, Tang WH, Greenberg BH, et al.; Music Investigators. Design and performance of a multisensor heart failure monitoring algorithm: results from the multisensor monitoring in congestive heart failure (MUSIC) study. J Card Fail. 2012;18(4):289–295. Epub 2012 Feb 14. doi:10.1016/j.cardfail.2012.01.009.
  • Vazquez R, Bayes-Genis A, Cygankiewicz I, et al.; MUSIC Investigators. The MUSIC Risk score: a simple method for predicting mortality in ambulatory patients with chronic heart failure. Eur Heart J. 2009;30(9):1088–1096. Epub 2009 Feb 24. doi:10.1093/eurheartj/ehp032.
  • Gasparini M, Auricchio A, Regoli F, et al. Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation. J Am Coll Cardiol. 2006;48(4):734–743. Epub 2006 Jul 24.
  • Linde C, Braunschweig F. Cardiac resynchronization therapy follow-up: role of remote monitoring. Card Electrophysiol Clin. 2015;7(4):797–807. Review. doi:10.1016/j.ccep.2015.08.010.
  • Walsh JA 3rd, Topol EJ, Steinhubl SR. Novel wireless devices for cardiac monitoring. Circulation. 2014;130(7):573–581. doi:10.1161/CIRCULATIONAHA.114.009024.
  • Lau JK, Lowres N, Neubeck L, et al. iPhone ECG application for community screening to detect silent atrial fibrillation: a novel technology to prevent stroke. Int J Cardiol. 2013;165(1):193–194. doi:10.1016/j.ijcard.2013.01.220.
  • Barrett PM, Komatireddy R, Haaser S, et al. Comparison of 24-hour Holter monitoring with 14-day novel adhesive patch electrocardiographic monitoring. Am J Med. 2014;127(1):95.e11–17. Epub 2013 Oct 15. doi:10.1016/j.amjmed.2013.10.003.
  • Engel JM, Mehta V, Fogoros R, et al. Study of arrhythmia prevalence in NUVANT Mobile Cardiac Telemetry system patients. Conf Proc IEEE Eng Med Biol Soc. 2012;2012:2440–2443. doi:10.1109/EMBC.2012.6346457.
  • Pollonini L, Rajan NO, Xu S, et al. A novel handheld device for use in remote patient monitoring of heart failure patients–design and preliminary validation on healthy subjects. J Med Syst. 2012;36(2):653–659. Epub 2010 Jun 8. doi:10.1007/s10916-010-9531-y.
  • Suh M-K, Evangelista LS, Chen V, et al. WANDA B.: weight and activity with blood pressure monitoring system for heart failure patients. IEEE Trans Inf Technol Biomed. 2010;14:1–6. doi:10.1109/WOWMOM.2010.5534983.
  • Koehler F, Winkler S, Schieber M, et al.; Telemedical Interventional Monitoring in Heart Failure Investigators. Impact of remote telemedical management on mortality and hospitalizations in ambulatory patients with chronic heart failure: the telemedical interventional monitoring in heart failure study. Circulation. 2011;123(17):1873–1880. Epub 2011 Mar 28. doi:10.1161/CIRCULATIONAHA.111.018473.
  • [cited 2016 Mar 20]. Available from: http://telemedizin.charite.de/en/research/partnership_for_the_heart/
  • Hofmann R, Völler H, Nagels K, et al.; CardioBBEAT Investigators. First outline and baseline data of a randomized, controlled multicenter trial to evaluate the health economic impact of home telemonitoring in chronic heart failure - CardioBBEAT. Trials. 2015;16:343. doi:10.1186/s13063-015-0886-8.
  • [cited 2016 Mar 20]. Available from: http://www.tunstall.co.uk/solutions/mymedicII
  • Inglis SC, Clark RA, McAlister FA, et al. Which components of heart failure programmes are effective? A systematic review and meta-analysis of the outcomes of structured telephone support or telemonitoring as the primary component of chronic heart failure management in 8323 patients: abridged Cochrane review. Eur J Heart Fail. 2011;13(9):1028–1040. Epub 2011 Jul 6. doi:10.1093/eurjhf/hfr039.
  • Steventon A, Ariti C, Fisher E, et al. Effect of telehealth on hospital utilisation and mortality in routine clinical practice: a matched control cohort study in an early adopter site. BMJ Open. 2016;6(2):e009221. doi:10.1136/bmjopen-2015-009221.
  • Forleo GB, Santini L, Campoli M, et al. Long-term monitoring of respiratory rate in patients with heart failure: the Multiparametric Heart Failure Evaluation in Implantable Cardioverter-Defibrillator Patients (MULTITUDE-HF) study. J Interv Card Electrophysiol. 2015;43(2):135–144. Epub 2015 Apr 28. doi:10.1007/s10840-015-0007-3.
  • Adamson PB, Smith AL, Abraham WT, et al.; InSync III Model 8042 and Attain OTW Lead Model 4193 Clinical Trial Investigators. Continuous autonomic assessment in patients with symptomatic heart failure: prognostic value of heart rate variability measured by an implanted cardiac resynchronization device. Circulation. 2004;110(16):2389–2394. Epub 2004 Aug 16.
  • Abraham WT. Disease management: remote monitoring in heart failure patients with implantable defibrillators, resynchronization devices, and haemodynamic monitors. Europace. 2013;15 Suppl 1:i40–i46. doi:10.1093/europace/eut105.
  • Braunschweig F, Ford I, Conraads V, et al.; DOT-HF steering committee and investigators. Can monitoring of intrathoracic impedance reduce morbidity and mortality in patients with chronic heart failure? Rationale and design of the Diagnostic Outcome Trial in Heart Failure (DOT-HF). Eur J Heart Fail. 2008;10(9):907–916. doi:10.1016/j.ejheart.2008.06.016.
  • Abraham WT, Compton S, Haas G, et al.; FAST Study Investigators. Intrathoracic impedance vs daily weight monitoring for predicting worsening heart failure events: results of the Fluid Accumulation Status Trial (FAST). Congest Heart Fail. 2011;17:51–55.
  • Goldberg LR, Piette JD, Walsh MN, et al.; WHARF Investigators. Randomized trial of a daily electronic home monitoring system in patients with advanced heart failure: the Weight Monitoring in Heart Failure (WHARF) trial. Am Heart J. 2003;146(4):705–712.
  • Cuba Gyllensten I, Bonomi AG, Goode KM, et al. Early indication of decompensated heart failure in patients on home-telemonitoring: a comparison of prediction algorithms based on daily weight and noninvasive transthoracic bio-impedance. JMIR Med Inform. 2016;4(1):e3. doi:10.2196/medinform.4842.
  • Conraads VM, Tavazzi L, Santini M, et al. Sensitivity and positive predictive value of implantable intrathoracic impedance monitoring as a predictor of heart failure hospitalizations: the SENSE-HF trial. Eur Heart J. 2011;32(18):2266–2273.
  • Landolina M, Perego GB, Lunati M, et al. Remote monitoring reduces healthcare use and improves quality of care in heart failure patients with implantable defibrillators: the evolution of management strategies of heart failure patients with implantable defibrillators (EVOLVO) study. Circulation. 2012;125(24):2985–2992. Epub 2012 May 24. doi:10.1161/CIRCULATIONAHA.111.088971.
  • Lüthje L, Vollmann D, Seegers J, et al. A randomized study of remote monitoring and fluid monitoring for the management of patients with implanted cardiac arrhythmia devices. Europace. 2015;17(8):1276–1281. Epub 2015 May 17. doi:10.1093/europace/euv039.
  • Reiter H, Muehlsteff J, Sipilä A. Medical application and clinical validation for reliable and trustworthy physiological monitoring using functional textiles: experience from the HeartCycle and MyHeart project. Conf Proc IEEE Eng Med Biol Soc. 2011;2011:3270–3273.
  • Whellan DJ, Ousdigian KT, Al-Khatib SM, et al.; PARTNERS Study Investigators. Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study. J Am Coll Cardiol. 2010;55(17):1803–1810. doi:10.1016/j.jacc.2009.11.089.
  • Sharma V, Rathman LD, Small RS, et al. Stratifying patients at the risk of heart failure hospitalization usingexisting device diagnostic thresholds. Heart Lung. 2015;44(2):129–136. Epub 2014 Dec 24. doi:10.1016/j.hrtlng.2014.07.007.
  • Cowie MR, Sarkar S, Koehler J, et al. Development and validation of an integrated diagnostic algorithm derived from parameters monitored in implantable devices for identifying patients at risk for heart failure hospitalization in an ambulatory setting. Eur Heart J. 2013;34(31):2472–2480. Epub 2013 Mar 19. doi:10.1093/eurheartj/eht083.
  • Small RS, Whellan DJ, Boyle A, et al. Implantable device diagnostics on day of discharge identify heart failure patients at increased risk for early readmission for heart failure. Eur J Heart Fail. 2014;16(4):419–425.
  • Mooney DM, Fung E, Doshi RN, et al. Evolution from electrophysiologic to hemodynamic monitoring: the story of left atrial and pulmonary artery pressure monitors. Front Physiol. 2015;6:271. eCollection 2015. doi:10.3389/fphys.2015.00271.
  • Verbrugge FH, Grieten L, Mullens W. Management of the cardiorenal syndrome in decompensated heart failure. Cardiorenal Med. 2014;4(3–4):176–188. Review. doi:10.1159/000366168.
  • Magalski A, Adamson P, Gadler F, et al. Continuous ambulatory right heart pressure measurements with an implantable hemodynamic monitor: a multicenter, 12-month follow-up study of patients with chronic heart failure. J Card Fail. 2002;8(2):63–70.
  • Bourge RC, Abraham WT, Adamson PB, et al.; COMPASS-HF Study Group. Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study. J Am Coll Cardiol. 2008;51(11):1073–1079. doi:10.1016/j.jacc.2007.10.061.
  • Adamson PB, Conti JB, Smith AL, et al. Reducing events in patients with chronic heart failure (REDUCEhf) study design: continuous hemodynamic monitoring with an implantable defibrillator. Clin Cardiol. 2007;30(11):567–575.
  • Walton AS, Krum H. The Heartpod implantable heart failure therapy system. Heart Lung Circ. 2005;14 Suppl 2:S31–S33. Epub 2005 Nov 9.
  • Ritzema J, Troughton R, Melton I, et al.; Hemodynamically Guided Home Self-Therapy in Severe Heart Failure Patients (HOMEOSTASIS) Study Group. Physician-directed patient self-management of left atrial pressure in advanced chronic heart failure. Circulation. 2010;121(9):1086–1095. Epub 2010 Feb 22. doi:10.1161/CIRCULATIONAHA.108.800490.
  • Adamson PB, Abraham WT, Aaron M, et al. CHAMPION trial rationale and design: the long-term safety and clinical efficacy of a wireless pulmonary artery pressure monitoring system. J Card Fail. 2011;17(1):3–10. doi:10.1016/j.cardfail.2010.08.002.
  • Abraham WT, Adamson PB, Bourge RC, et al.; CHAMPION Trial Study Group. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet. 2011;377(9766):658–666. Erratum in: Lancet. 2012 Feb 4;379. doi:10.1016/S0140-6736(11)60101-3.
  • Kourouklis SP, Vagiakis E, Paraskevaidis IA, et al. Tailored treatment of sleep disordered breathing in patients with chronic heart failure improves cardiac function. Int J Cardiol. 2013;168(4):4529. Epub 2013 Jul 24. doi:10.1016/j.ijcard.2013.06.101.
  • Fox H, Oldenburg O, Nölker G, et al. [Detection and therapy of respiratory dysfunction by implantable (cardiac) devices]. Herz. 2014;39(1):32–36. Review. German. doi:10.1007/s00059-014-4062-9.
  • Abraham WT, Jagielski D, Oldenburg O, et al.; remedē Pilot Study Investigators. Phrenic nerve stimulation for the treatment of central sleep apnea. JACC Heart Fail. 2015;3(5):360–369. Epub 2015 Mar 11. doi:10.1016/j.jchf.2014.12.013.
  • Fox H, Bitter T, Gutleben KJ, et al. Cardiac or other implantable electronic devices and sleep-disordered breathing - implications for diagnosis and therapy. Arrhythm Electrophysiol Rev. 2014;3(2):116–119. Epub 2014 Aug 30. doi:10.15420/aer.2014.3.2.116.
  • Kourouklis SP, Vagiakis E, Paraskevaidis IA, et al. Effective sleep apnoea treatment improves cardiac function in patients with chronic heart failure. Int J Cardiol. 2013;168(1):157–162. Epub 2012 Oct 2. doi:10.1016/j.ijcard.2012.09.101.
  • Forleo GB, Tesauro M, Panattoni G, et al. Impact of continuous intracardiac ST-segment monitoring on mid-term outcomes of ICD-implanted patients with coronary artery disease. Early results of a prospective comparison with conventional ICD outcomes. Heart. 2012;98(5):402–407. Epub 2011 Nov 23. doi:10.1136/heartjnl-2011-300801.
  • Papavasileiou LP, Forleo GB, Romeo F. Early detection of chronic myocardial ischemia in a patient implanted with an ICD capable of intracardiac electrogram monitoring. J Invasive Cardiol. 2011;23(12):532–533.
  • Klack L, Schmitz-Rode T, Wilkowska W, et al. Integrated home monitoring and compliance optimization for patients with mechanical circulatory support devices. Ann Biomed Eng. 2011;39(12):2911–2921. Epub 2011 Oct 13. doi:10.1007/s10439-011-0407-1.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.